The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis - PubMed (original) (raw)
The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis
D M Gerlag et al. J Immunol. 2000.
Abstract
NF-kappa B plays a key role in the production of cytokines in inflammatory diseases. The effects of a novel T cell-specific NF-kappa B inhibitor, SP100030, were evaluated in cultured Jurkat cells and in murine collagen-induced arthritis (CIA). Chemical libraries were screened for NF-kappa B-inhibitory activity. SP100030, a compound identified in this process, inhibited NF-kappa B activation in PMA/PHA-activated Jurkat cells by EMSA at a concentration of 1 microM. Jurkat cells and the monocytic cell line THP-1 were transfected with an NF-kappa B promotor/luciferase construct and activated. SP100030 inhibited luciferase production in the Jurkat cells (IC50 = 30 nM). ELISA and RT-PCR confirmed that IL-2, IL-8, and TNF-alpha production by activated Jurkat and other T cell lines were inhibited by SP100030. However, cytokine expression was not blocked by the compound in THP-1 cells, fibroblasts, endothelial cells, or epithelial cells. Subsequently, DBA/1J mice were immunized with type II collagen. Treatment with SP100030 (10 mg/kg/day i.p. beginning on day 21) significantly decreased arthritis severity from onset of clinical signs to the end of the study on day 34 (arthritis score, 5.6 +/- 1.7 for SP100030 and 9.8 +/- 1.5 for control; p < 0.001). Histologic evaluation demonstrated a trend toward improvement in SP100030-treated animals. EMSA of arthritic mouse ankles in CIA showed that synovial NF-kappa B binding was suppressed in the SP100030-treated mice. SP100030 inhibits NF-kappa B activation in T cells, resulting in reduced NF-kappa B-regulated gene expression and decreased CIA. Its selectivity for T cells could provide potent immunosuppression with less toxicity than other NF-kappa B inhibitors.
Similar articles
- Essential role of T cell NF-kappa B activation in collagen-induced arthritis.
Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen J. Seetharaman R, et al. J Immunol. 1999 Aug 1;163(3):1577-83. J Immunol. 1999. PMID: 10415062 - Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Joosten LA, et al. Arthritis Res. 1999;1(1):81-91. doi: 10.1186/ar14. Epub 1999 Oct 26. Arthritis Res. 1999. PMID: 11056663 Free PMC article. - Inhibition of nuclear factor-kappaB in T cells suppresses lung fibrosis.
Fujimoto H, D'Alessandro-Gabazza CN, Palanki MS, Erdman PE, Takagi T, Gabazza EC, Bruno NE, Yano Y, Hayashi T, Tamaki S, Sumida Y, Adachi Y, Suzuki K, Taguchi O. Fujimoto H, et al. Am J Respir Crit Care Med. 2007 Dec 15;176(12):1251-60. doi: 10.1164/rccm.200609-1288OC. Epub 2007 Sep 27. Am J Respir Crit Care Med. 2007. PMID: 17901412 - IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB. Lubberts E, et al. J Immunol. 2003 Mar 1;170(5):2655-62. doi: 10.4049/jimmunol.170.5.2655. J Immunol. 2003. PMID: 12594294
Cited by
- Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
Konturek PC, Rembiasz K, Burnat G, Konturek SJ, Tusinela M, Bielanski W, Rehfeld J, Karcz D, Hahn E. Konturek PC, et al. Dig Dis Sci. 2006 Apr;51(4):779-87. doi: 10.1007/s10620-006-3206-z. Dig Dis Sci. 2006. PMID: 16615003 - NOD2 allele variants in patients with rheumatoid arthritis.
Pawlik A, Kurzawski M, Gawronska-Szklarz B, Drozdzik M, Herczynska M. Pawlik A, et al. Clin Rheumatol. 2007 Jun;26(6):868-71. doi: 10.1007/s10067-006-0404-1. Epub 2006 Sep 15. Clin Rheumatol. 2007. PMID: 16977346 - Botanical Extracts from Rosehip (Rosa canina), Willow Bark (Salix alba), and Nettle Leaf (Urtica dioica) Suppress IL-1β-Induced NF-κB Activation in Canine Articular Chondrocytes.
Shakibaei M, Allaway D, Nebrich S, Mobasheri A. Shakibaei M, et al. Evid Based Complement Alternat Med. 2012;2012:509383. doi: 10.1155/2012/509383. Epub 2012 Mar 14. Evid Based Complement Alternat Med. 2012. PMID: 22474508 Free PMC article. - Studies of T-cell activation in chronic inflammation.
Cope AP. Cope AP. Arthritis Res. 2002;4 Suppl 3(Suppl 3):S197-211. doi: 10.1186/ar557. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110140 Free PMC article. Review. - RIPK1-Associated Inborn Errors of Innate Immunity.
Zhang J, Jin T, Aksentijevich I, Zhou Q. Zhang J, et al. Front Immunol. 2021 Jun 7;12:676946. doi: 10.3389/fimmu.2021.676946. eCollection 2021. Front Immunol. 2021. PMID: 34163478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources